Trial on Thumbtack Needle for Menopausal Insomnia Now Recruiting

A clinical trial update dated October 27, 2026 lists a study titled "Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women." The trial is registered under identifier NCT07229976. According to the listing, the study status is recruiting. The phase is listed as not applicable. This update is associated with corticorelin, which carries an approved regulatory status. No outcome data, efficacy claims, or safety findings are included in this update. The listing does not specify enrollment numbers, study duration, or additional design details beyond status and phase. Readers should note that a trial being in the recruiting stage indicates it is currently open for participant enrollment and has not yet reported results. No results have been posted for this study as of the date given. This brief reflects only the information provided in the trial record as of the stated date and does not include any interpretation of expected outcomes. For more background on corticorelin, including its approved uses and general profile, readers can consult the compound overview.